How AI Is Aiming at the Bad Math of Drug Development

Nov 29, 2021
Robert Marcus

Related news

Nov 15
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Investment Into Biosciences Boomed With COVID, But Could The Bubble Burst?

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Exscientia Files For $100M IPO

Nov 15
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Artificial Intelligence In Drug Discovery

Oct 25
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Artificial Intelligence Is Transforming Biotechnology, Especially When It Comes To Innovations In Nitric Oxide

Aug 2
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI breakthrough could spark medical revolution

Oct 19
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Venture capital firm Sofinnova raises 472 mln euros to focus on healthcare start-ups

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Exscientia Files For $100M IPO

May 17
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Discovering the next unicorn founder with data, not gut instinct

Sep 23
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Unicorn Report: Visualizing The Increasingly Crowded Billion-Dollar Company Club

Sep 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gathering Strength, Gathering Storms: The One Hundred Year Study on Artificial Intelligence (AI100) 2021 Study Panel Report

Oct 4
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Reportable Launches Media Monitoring Service for Biotech, Medical Device and Pharmaceutical Companies

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Women less likely to win major research awards